Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.

The high-dose regimen of SPINRAZA (nusinersen) is approved in the European Union and Japan. The high-dose regimen is under review with the United States Food and Drug Administration (FDA) and has a ...

RIoT offers their annual, bi-partisan, collaborative State of the Region address to highlight opportunities and growth across the State of North Carolina.

Cotton-blend comfort meets durable water repellency in a loose-fit jacket that layers easily and now costs far less.

BEREA, Ohio — The Todd Monken era officially began for the Browns on Tuesday, when Cleveland’s new head coach had his ...

Heart failure (HF) is a chronic and progressive cardiovascular condition associated with significant morbidity, mortality and ...

The Super Bowl halftime show, lasting about 13 minutes, has sparked decades of conversation. Iconic moments include Janet Jackson and Justin Timberlake's “wardrobe malfunction” and ...

According to MarketsandMarketstm, The nutraceutical gummies market is estimated at USD 24.39 billion in 2025 and is projected to reach USD 47.80 billion by 2030, at a CAGR of 14.4% during the same ...

Advocates want marijuana legalized for all adults, not just for those with qualifying medical conditions. But opponents fear legalization could hurt tourism, create enforcement challenges and damage ...

The first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. DS3790 is a specifically engineered, ...